Back to Search
MANUEL MACAPINLAC, M.D.
M.D.
Medical Oncology Physician
NPI: 1811975345IndividualAccepts Medicare
Specialties, Licenses & Credentials
Hematology (Internal Medicine) Physician
Internal Medicine — Hematology
Code: 207RH0000X
61535062(WA)
Medical Oncology PhysicianPrimary
Internal Medicine — Medical Oncology
Code: 207RX0202X
61535062(WA)
CMS Specialties
PrimaryMEDICAL ONCOLOGY
Education
OTHER
Class of 1991
Research & Publications (3)
A phase I safety and dose escalation trial of docetaxel combined with GEM231, a second generation antisense oligonucleotide targeting protein kinase A R1alpha in patients with advanced solid cancers.
PMID 16683205·Invest New Drugs·2006
3-trial
The clinical development of new mitotic inhibitors that stabilize the microtubule.
PMID 15205596·Anticancer Drugs·2004
6-review
Phase I study of amifostine as a cytoprotector of the gemcitabine/cisplatin combination in patients with advanced solid malignancies.
PMID 12679737·Anticancer Drugs·2003
3-trial
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- OLYMPIC MEDICAL CANCER CENTER, 844 N 5TH AVE
SEQUIM, WA 98382 - Phone
- (360) 683-9895
Quick Facts
- NPI
- 1811975345
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 2
- Locations
- 1
- Years in Practice
- 35
- Publications
- 3
Are you this provider?
Claim Your Profile